Younger Kidney Cancer Patients on VEGF Inhibitors at Elevated Risk for Hypertension
WEDNESDAY, July 26, 2023 (HealthDay News) — Hypertension during treatment is common among adolescents and young adults (AYAs) being treated with vascular endothelial growth factor (VEGF) inhibitors for renal cancer, according to a study published onl…
Learn MoreThe Earlier MS Is Treated, the Better
WEDNESDAY, July 26, 2023 (HealthDay News) — Patients who get treatment for multiple sclerosis at the earliest signs of disease may have a lower risk of disability later, new research suggests.Among nearly 600 patients, there were lower odds of disabi…
Learn MoreSGLT2i Use Linked to Reduced Risk for Flare in Adults With Gout, T2D
MONDAY, July 24, 2023 (HealthDay News) — For patients with gout and type 2 diabetes, sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for recurrent gout flares and gout-primary emergency department visits and hos…
Learn MoreMajor Drug Shortages Not Likely After Tornado Damages Pfizer Plant, FDA Says
MONDAY, July 24, 2023 (HealthDay News) — Tornado damage to a Pfizer drug-making plant in North Carolina is unlikely to trigger drug shortages across the country, the U.S. Food and Drug Administration says.
“We do not expect there to be any immediate …
Are These Pricey New Alzheimer’s Drugs Worth It?
MONDAY, July 24, 2023 (HealthDay News) — Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research.The fact that patients’ mental deterioration slows when they’re on anti-amyloid dr…
Learn MoreAre These Pricey New Alzheimer’s Drugs Worth It?
MONDAY, July 24, 2023 (HealthDay News) — Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research.The fact that patients’ mental deterioration slows when they’re on anti-amyloid dr…
Learn MoreMajor Drug Shortages Not Likely After Tornado Damages Pfizer Plant, FDA says
MONDAY, July 24, 2023 (HealthDay News) — Tornado damage to a Pfizer drug-making plant in North Carolina is unlikely to trigger drug shortages across the country, the U.S. Food and Drug Administration says. “We do not expect there to be any immediate …
Learn MoreKetamine Efficacious for Treatment-Resistant Depression
FRIDAY, July 21, 2023 (HealthDay News) — A four-week treatment course of racemic ketamine is efficacious and safe for treatment-resistant depression (TRD), according to a study published online July 14 in the British Journal of Psychiatry.Colleen Loo…
Learn MoreKetamine Efficacious for Treatment-Resistant Depression
FRIDAY, July 21, 2023 (HealthDay News) — A four-week treatment course of racemic ketamine is efficacious and safe for treatment-resistant depression (TRD), according to a study published online July 14 in the British Journal of Psychiatry.Colleen Loo…
Learn MoreFruquintinib Provides Meaningful Benefit in Refractory Metastatic CRC
THURSDAY, July 20, 2023 (HealthDay News) — For patients with refractory metastatic colorectal cancer, fruquintinib treatment yields a significant and clinically meaningful benefit in terms of overall survival, according to a study published in the Ju…
Learn More